Oct 15, 2026 · 51 min · 16 segments
**He Built an AI-Powered Business Offering WHOLESALE Prescription Peptides | Marcus Hansen** What if prescription peptides were available at wholesale prices? And what if AI could help entrepreneurs…
How, how much of, um, you know, similarities do you c- find this to be with like when Mark Cuban talks about what he's doing with healthcare and he wants to make it affordable.
You know, i- is, is there a correlation? Could there be some synergies later down the road with all that you have going on?
Yeah, with Mark Cuban, what he's doing with, you know, the, the, the medicine.
You also have companies like Amazon that are, that are building out the same aspects, um, that have better distribution and so forth.
And so as soon as you can bring those two together, that's where the consumer's gonna win, in theory.
It's kind of like, um, Eastern verse Western medicine, and it's more Eastern style of kinda like, well, what does BPC-157 actually do? What's the research backing a growth hormone analog that will help you build muscle? What is happening in the space right now is more around research than it is anything else, and as soon as the research is done and the FDA passes a few of these peptides through, you're gonna see a large boom in online providers like Hims and Hers, Ro.
I know that Noom has purchased an actual facility to manufacture peptides, so there's quite a bit going on in that space where the larger people are gonna jump in because everyone's talking about it, everyone wants it.
The problem that I see coming is that those companies will want to have their markup, right? Just like they do now on anything else they sell as far as medicine is concerned.
The consumer typically can't afford it, right? M- most people in America are unable to spend $450 a month for a couple peptides, right? That's a lot of money.
And so the alternative is going direct to a pharmacy with a prescription, and that's what we do.
And, and what do you think about, I know Amazon Pharmacy, some people they say, "It's so new.
I need to go, you know, still to the brick and mortar." Um, so I think that's where Mark and Amazon, I think they've partnered, and I guess, you know, a l- uh, probably a lot of drug companies wanna be on Amazon Pharmacy.
Are you finding, um, that to be, you know, maybe a, a future partner? Uh, are they letting you in the doors? Is it that peptides, to what you were just saying, is still, you know, it, it, it's too new sometimes until they can make the money that they need.
And we hear the FDA may be making some changes, um, you know, within a year.
How, how much of, um, you know, similarities do you c- find this to be with like when Mark Cuban talks about what he's doing with healthcare and he wants to make it affordable.
You know, i- is, is there a correlation? Could there be some synergies later down the road with all that you have going on?
Yeah, with Mark Cuban, what he's doing with, you know, the, the, the medicine.
You also have companies like Amazon that are, that are building out the same aspects, um, that have better distribution and so forth.
And so as soon as you can bring those two together, that's where the consumer's gonna win, in theory.
It's kind of like, um, Eastern verse Western medicine, and it's more Eastern style of kinda like, well, what does BPC-157 actually do? What's the research backing a growth hormone analog that will help you build muscle? What is happening in the space right now is more around research than it is anything else, and as soon as the research is done and the FDA passes a few of these peptides through, you're gonna see a large boom in online providers like Hims and Hers, Ro.
I know that Noom has purchased an actual facility to manufacture peptides, so there's quite a bit going on in that space where the larger people are gonna jump in because everyone's talking about it, everyone wants it.
The problem that I see coming is that those companies will want to have their markup, right? Just like they do now on anything else they sell as far as medicine is concerned.
The consumer typically can't afford it, right? M- most people in America are unable to spend $450 a month for a couple peptides, right? That's a lot of money.
And so the alternative is going direct to a pharmacy with a prescription, and that's what we do.
And, and what do you think about, I know Amazon Pharmacy, some people they say, "It's so new.
I need to go, you know, still to the brick and mortar." Um, so I think that's where Mark and Amazon, I think they've partnered, and I guess, you know, a l- uh, probably a lot of drug companies wanna be on Amazon Pharmacy.
Are you finding, um, that to be, you know, maybe a, a future partner? Uh, are they letting you in the doors? Is it that peptides, to what you were just saying, is still, you know, it, it, it's too new sometimes until they can make the money that they need.
And we hear the FDA may be making some changes, um, you know, within a year.
The rest of this transcript — segmented and speaker-labeled, so you land on the exact moment something was said
Search every transcript — by keyword, by phrase, or by meaning, across every show Radar indexes
Trends — what is surging across podcasts, measured against its own baseline
Alerts — when a name you follow appears in a newly indexed episode
No account is needed to search Radar.